BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Antibody Drug Conjugates

CStone Pharmaceuticals Submits Clinical Trial Application in Australia for CS2009, a Tri-Specific Antibody Targeting Solid Tumors

CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therap...

December 23, 2024 | News

OmniAb Showcases Multispecific Antibody Workflow and Launches OmniHub™ at AETC 2024

Presentations included a case study of the workflow for building multispecifics and the launch of OmniHub™, a bioinformatics tools platform ...

December 17, 2024 | News

SK Biopharmaceuticals and ProEn Therapeutics to Develop Two Radiopharmaceutical Candidates by 2027 Using ArtBody™ Platform

SK Biopharmaceuticals, ProEn Therapeutics aim to advance up to 2 preclinical radiopharmaceutical candidates by 2027, via ArtBody™, a bivalent binder ...

December 17, 2024 | News

Porton Pharma Solutions and Aojin Life Sciences Forge Strategic Partnership to Advance XDC Conjugate Drug Development

Porton Pharma Solutions Ltd. ("Porton") announced a strategic partnership with Aojin Life Sciences (Yixing) Co., Ltd. ("Aojin Life Sciences"). Porton will...

December 13, 2024 | News

Asahi Kasei Pharma Expands Global Reach with Exclusive Anti-CX3CR1 Antibody License

Asahi Kasei Pharma has taken another significant step toward becoming a leading global specialty pharmaceutical company by entering an exclusive license ag...

December 12, 2024 | News

Nona Biosciences Partners with Kodiak Sciences to Accelerate Multi-Target Antibody Therapies for Ophthalmic Diseases

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody disc...

December 10, 2024 | News

Ono Pharmaceutical Partners with Congruence Therapeutics to Advance Oncology Drug Discovery

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") announced that it has entered into a drug discove...

December 09, 2024 | News

Gilead Sciences and Tubulis Forge Strategic Partnership to Advance Antibody-Drug Conjugates for Solid Tumors

Gilead Sciences, Inc. and Tubulis announced that they have entered into an exclusive option and license agreement to discover and develop a...

December 05, 2024 | News

Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Approved for Pediatric Use in Hong Kong

Pfizer announced that the Hong Kong Department of Health (DoH) has approved its 20-valent Pneumococcal Conjugate Vaccine (PCV20) for active immunization in...

December 04, 2024 | News

Duality Biologics and GSK Forge $1 Billion Partnership for Next-Generation ADC Candidate

Duality Biologics ("DualityBio"), a clinical-stage biotech company focusing on the discovery and development of next-generation antibody-drug conjugate (AD...

December 04, 2024 | News

Allink Biotherapeutics Secures $42 Million Series A Funding to Drive Global Expansion of Next-Gen ADC and Bispecific Antibody Therapies

Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutic...

November 29, 2024 | News

Kelun-Biotech Secures China’s First Approval for TROP2-Directed ADC Sacituzumab Tirumotecan for Advanced Triple-Negative Breast Cancer

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from ...

November 28, 2024 | News

Duality Biologics and Adcendo Expand Collaboration to Strengthen ADC Cancer Therapy Pipeline

Duality Biologics ("Duality"), a clinical-stage biotech company focusing on the discovery and development of next generation antibody-drug conjugate therap...

November 26, 2024 | News

Lepu Biopharma and DP Technology Achieve Milestone in ADC Drug Development Through AI-Powered Collaboration

This partnership has effectively integrated DP's ADC Linker-Payload design platform with Lepu's ADC technology development platform, capitalizing on t...

November 22, 2024 | News

Stay Connected